Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement
The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday.
Stay updated with breaking news from Kare Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday.
Teva CEO Kare Schultz said that despite sanctions, Teva still sells medications to Russia, because this is a humanitarian move. He also revealed that Teva donates medicines to Ukraine.
Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its chief executive
By Steven Scheer TEL AVIV (Reuters) - Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and start
By Steven Scheer TEL AVIV (Reuters) - Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and sta...